Nom du produit:2-methyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxylic acid

IUPAC Name:2-methyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxylic acid

CAS:18955-88-9
Formule moléculaire:C6H4F3NO3
Pureté:95%+
Numéro de catalogue:CM379626
Poids moléculaire:195.1

Unité d'emballage Stock disponible Prix($) Quantité
CM379626-250mg in stock ƏƩŭ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:18955-88-9
Formule moléculaire:C6H4F3NO3
Point de fusion:-
Code SMILES:CC1=NC(C(O)=O)=C(O1)C(F)(F)F
Densité:
Numéro de catalogue:CM379626
Poids moléculaire:195.1
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Oxazoles
Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.